Catalyst Wire Dossier Catalyst Wire Dossier

OROS Oxybutynin Chloride

oxybutynin chloride · Alza Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OROS Oxybutynin Chloride, covering 2011-05-19 to 2011-05-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence [Phase 3]

See pricing